It is completely natural to have questions about long-term side effects before starting or continuing any medication, and Mounjaro is no different. With weight loss injections becoming increasingly discussed across the UK, many people want to feel genuinely informed and reassured before committing to treatment.
The good news is that Mounjaro has been studied extensively, and for the vast majority of people, it is well tolerated over time. Understanding what the evidence currently shows, what to look out for, and how to access ongoing support can make a real difference to your confidence throughout treatment.
If you have questions about Mounjaro or would like to talk through your options with a knowledgeable team, contact us or book a consultation with us at Mendus Pharmacy in Pembroke. We are here to help.
What Is Mounjaro and How Does It Work?
Mounjaro is a dual GIP and GLP-1 receptor agonist, meaning it acts on two hormones that play a role in appetite regulation, digestion, and blood sugar control. It is administered once weekly via a pre-filled injection pen and is prescribed alongside a reduced-calorie diet and increased physical activity.
It has been licensed for use in the UK for weight management in adults with a BMI of 30 or above, or 27 or above where a weight-related health condition is present. Clinical trials have shown it to be highly effective, with many participants achieving significant and sustained weight loss over the course of treatment.
Short-Term vs Long-Term Side Effects: Understanding the Difference
It is helpful to separate short-term side effects, which are common and usually temporary, from longer-term considerations that may develop over extended periods of use.
| Side Effect Type | Examples | When It Typically Occurs | What Usually Happens Over Time |
|---|---|---|---|
| Short-term / early | Nausea, vomiting, diarrhoea, fatigue | First few weeks or after dose increases | Improves as the body adjusts |
| Ongoing / manageable | Constipation, reduced appetite, injection site reactions | May persist at lower levels throughout treatment | Usually mild and manageable with lifestyle adjustments |
| Longer-term considerations | Muscle mass changes, gallbladder issues, thyroid monitoring | Associated with extended use or significant weight loss | Monitored through regular clinical review |
For most patients, side effects are concentrated in the early stages of treatment and reduce considerably once a stable dose is reached. This is an important and reassuring point to hold on to if you are feeling apprehensive.
What Does Current Evidence Say About Long-Term Use?
Mounjaro has been evaluated in large-scale clinical trials, including the SURMOUNT programme, which followed participants over periods of up to 72 weeks. The results showed not only sustained weight loss but also improvements in cardiovascular risk markers, blood pressure, and blood sugar levels for many participants.
According to the NHS, most side effects associated with tirzepatide are gastrointestinal in nature and are most commonly reported during the dose escalation phase. Serious adverse events are uncommon, and the benefit-to-risk profile is considered favourable for those who meet the prescribing criteria.
It is worth noting that Mounjaro is a relatively recent addition to the UK market, and as with all newer medicines, post-market surveillance continues to build the evidence base over time. This is standard practice for any licensed medication and is not a cause for concern in itself.
Long-Term Side Effects: What To Be Aware Of
Being informed about potential longer-term considerations is empowering, not alarming. The following points reflect current clinical knowledge and are areas your healthcare provider will be mindful of during ongoing treatment.
Muscle mass changes: Significant calorie restriction during weight loss, whether medication-assisted or not, can result in some loss of lean muscle mass. This is not unique to Mounjaro. Prioritising protein intake and incorporating resistance exercise can help preserve muscle effectively during treatment.
Gallbladder health: Rapid weight loss is associated with an increased risk of gallstones, regardless of the method used to achieve it. This is something your clinician will be aware of and can monitor where appropriate. Symptoms such as persistent upper abdominal pain should be reported promptly.
Thyroid considerations: In animal studies, tirzepatide was associated with thyroid cell changes, which is why it is not recommended for those with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. It is important to stress that these findings were in animal studies and have not been replicated in human trials to date. Your prescriber will have screened for these factors before recommending treatment.
Pancreatitis: There is a small theoretical risk of pancreatitis with GLP-1 receptor agonists. If you experience severe or persistent abdominal pain, you should seek medical advice. Those with a history of pancreatitis are generally not prescribed this class of medication.
Nutritional considerations: Because Mounjaro significantly reduces appetite, there is a risk of insufficient nutrient intake over time if meals are not carefully planned. Ensuring a varied, nutrient-dense diet and speaking with your clinician about any supplementation needs is advisable for longer-term users.
Reassurance: What This Means in Practice
Reading through a list of potential side effects can feel daunting, but context matters enormously here. The considerations above are monitored as a matter of routine by healthcare professionals, and the majority of people taking Mounjaro do not experience serious complications.
Key reasons to feel reassured include:
- Mounjaro has undergone rigorous clinical trials involving tens of thousands of participants
- It is licensed by the MHRA, meaning it has met strict safety and efficacy standards for use in the UK
- Most side effects are mild to moderate and concentrated in the early stages of treatment
- Serious adverse events are uncommon in clinical data
- Regular clinical review allows any emerging concerns to be identified and addressed early
- The benefits of sustained weight loss, including improvements in cardiovascular health, blood sugar, and joint health, are well documented
Weight management is about long-term health, and for many people, the health risks associated with obesity far outweigh the potential risks of a well-monitored medication.
Could Wegovy Be an Alternative If You Have Concerns?
If you have read about Mounjaro’s side effect profile and find yourself hesitant, it is worth knowing that there are alternatives available. Wegovy (semaglutide) is another injectable weight loss treatment that works via a similar mechanism, acting on GLP-1 receptors to reduce appetite and support weight loss.
Wegovy has been available for longer than Mounjaro and therefore has a slightly more established long-term evidence base in clinical practice. Its side effect profile is broadly comparable, with nausea, digestive symptoms, and fatigue also being the most commonly reported effects.
Some patients find one medication suits them better than the other, and a consultation with a healthcare professional is the best way to explore which option aligns with your health history, preferences, and goals. Both treatments require professional assessment before prescribing, and neither should be started without appropriate clinical support.
Hints and Tips: Managing Your Treatment With Confidence
To get more handy advice to support your weight loss, click on the boxes below:
Keep a symptom diary throughout treatment
Noting any side effects, their severity, and when they occur gives your healthcare provider valuable information at review appointments. It also helps you spot patterns, such as symptoms that are worse on injection day, so that adjustments can be made where possible.
Prioritise protein and resistance exercise
To protect muscle mass during weight loss, aim to include a good protein source at every meal and incorporate some form of resistance or strength training into your weekly routine. Even light bodyweight exercises or resistance bands can make a meaningful difference over time.
Attend all follow-up appointments
Regular clinical reviews are an important part of safe, effective treatment. They allow your healthcare provider to monitor progress, assess any side effects, and make dose adjustments if needed. Do not skip appointments even if you feel your treatment is going well.
Report any new or unusual symptoms promptly
If you experience symptoms that feel unusual or persistent, such as severe abdominal pain, significant changes in mood, or signs of an allergic reaction, seek medical advice without delay. Early reporting means any issues can be assessed and managed quickly.
Ask questions at every stage
There is no such thing as an unnecessary question when it comes to your health. If something is worrying you about your treatment, speak to your healthcare provider. Feeling informed and supported makes a real difference to how confidently you can approach long-term treatment.
Frequently Asked Questions
➤ Is Mounjaro safe to take long term?
Based on current clinical evidence, Mounjaro is considered safe for long-term use in appropriate patients. It is licensed by the MHRA and has been evaluated in large-scale trials. As with all medications, it is used under clinical supervision with regular review.
➤ Will side effects get worse over time on Mounjaro?
For most people, side effects are most pronounced during the early stages of treatment or following dose increases. They tend to improve rather than worsen over time as the body adjusts to the medication.
➤ Can I stop Mounjaro if I am concerned about side effects?
You should not stop taking Mounjaro suddenly without speaking to your healthcare provider first. If you have concerns about side effects, raising them at your next appointment or contacting your provider sooner allows for a proper review of your treatment.
➤ How is long-term safety monitored?
Regular clinical reviews, combined with ongoing post-market surveillance by the MHRA, contribute to the monitoring of long-term safety. Your prescriber will also assess any relevant health markers at follow-up appointments throughout your treatment.
➤ Is Wegovy safer than Mounjaro long term?
Both medications have broadly comparable side effect profiles. Wegovy has a slightly longer post-market history in some countries, but both are licensed treatments with well-evaluated safety data. A healthcare professional can help you weigh up which is more appropriate for your individual circumstances.
Important Note
This blog is intended as a general informational guide only and does not constitute medical advice. Individual experiences of side effects vary, and the information provided here should not replace a conversation with a qualified healthcare professional. Please contact us or visit us in Pembroke for advice tailored to your personal health and treatment needs.
Here to Support You Every Step of the Way in Pembroke
Deciding to start a weight loss treatment is a significant and positive step, and it is entirely reasonable to want to feel fully informed before doing so. The evidence surrounding Mounjaro is encouraging, and with proper clinical support, the vast majority of patients are able to manage their treatment safely and effectively over the long term.
Our team at Mendus Pharmacy in Pembroke is here to answer your questions, address any concerns, and make sure you feel confident and well supported throughout your journey. You do not have to navigate this alone.
Reach out to us today or book a consultation with Mendus Pharmacy and take the next step with confidence.